events
Meet our team at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society in October 6-9 for expert consultation on your drug discovery projects. Shoot an email to arrange an in-person meeting.
Read More

Nucleosides

  1. Home
  2. Products & Services
  3. Products
  4. RNA Synthesis Reagents
  5. Nucleosides
2'-Modified Nucleosides
(290/290) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(237/237) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(135/135) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

Molnupiravir Dimethyl Dioxol Impurity

Description: An impurity of Molnupiravir which is an antiviral drug with promising activity against the SARS-​CoV-​2 virus.
CAT: BRP-01942
CAS: 2346620-55-9
MF: C16H23N3O7
MF: 369.37
Purity: 97%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.51±0.1 g/cm3
InChIKey: MNKXNZQOZRWRKB-OJAKKHQRSA-N
CanonicalSMILES: CC(C)C(=O)OCC1C2C(C(O1)N3C=CC(=NC3=O)NO)OC(O2)(C)C
IUPAC Name: [(3aR,4R,6R,6aR)-4-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
InChI: InChI=1S/C16H23N3O7/c1-8(2)14(20)23-7-9-11-12(26-16(3,4)25-11)13(24-9)19-6-5-10(18-22)17-15(19)21/h5-6,8-9,11-13,22H,7H2,1-4H3,(H,17,18,21)/t9-,11-,12-,13-/m1/s1
Synonyms: Uridine, 2',3'-O-(1-methylethylidene)-, 4-oxime, 5'-(2-methylpropanoate); 2',3'-O-(1-Methylethylidene)uridine 4-Oxime 5'-(2-Methylpropanoate); ((3aR,4R,6R,6aR)-6-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate

(2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(4'-chloro-5,5'-diiodo-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-7-yl)tetrahydrofuran-3,4-diyl dibenzoate

Description: (2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(4'-chloro-5,5'-diiodo-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-7-yl)tetrahydrofuran-3,4-diyl dibenzoate is a synthetic compound with potential anti-cancer efficacy. It mainly interferes with DNA replication and transcription, and is used in studies targeting genetic diseases and cancer.
CAT: BRP-01945
MF: C38H25ClI2N6O7
MF: 966.90
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.9±0.1 g/cm3
Boiling Point: 900.4±65.0 °C at 760 mmHg
InChIKey: MYTJWTXUMTUHKX-OAFMTEKMSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)N3C=C(C4=C3N=CN=C4N5C=C(C6=C5N=CN=C6Cl)I)I)OC(=O)C7=CC=CC=C7)OC(=O)C8=CC=CC=C8
IUPAC Name: [(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-[4-(4-chloro-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-5-iodopyrrolo[2,3-d]pyrimidin-7-yl]oxolan-2-yl]methyl benzoate
InChI: InChI=1S/C38H25ClI2N6O7/c39-31-27-24(40)16-46(32(27)43-19-42-31)33-28-25(41)17-47(34(28)45-20-44-33)35-30(54-38(50)23-14-8-3-9-15-23)29(53-37(49)22-12-6-2-7-13-22)26(52-35)18-51-36(48)21-10-4-1-5-11-21/h1-17,19-20,26,29-30,35H,18H2/t26-,29-,30-,35-/m1/s1
Synonyms: 4'-Chloro-5,5'-diiodo-7-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine

2,4-Dithiouridine

Description: 2,4-Dithiouridine is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its sulfur substitution at the 2 and 4 positions of the uracil base allows scientists to study the effects of such modifications on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.
CAT: BRP-01946
CAS: 13239-96-8
MF: C9H12N2O4S2
MF: 276.33
Purity: 98%
Appearance: Yellow Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.73±0.1 g/cm3
Melting Point: >146 °C
Boiling Point: 511.7±60.0 °C at 760 mmHg
InChIKey: OKYRYFXQZRFDQL-XVFCMESISA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: C1=CN(C(=S)NC1=S)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dithione
InChI: InChI=1S/C9H12N2O4S2/c12-3-4-6(13)7(14)8(15-4)11-2-1-5(16)10-9(11)17/h1-2,4,6-8,12-14H,3H2,(H,10,16,17)/t4-,6-,7-,8-/m1/s1
Synonyms: 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dithione; 2,4-Dithio-uridine

1-Methyladenosine hydroiodide

Description: 1-Methyladenosine hydroiodide is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its methylation at the N1 position and presence as a hydroiodide salt allows scientists to study the effects of such modifications on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.
CAT: BRP-01947
CAS: 34308-25-3
MF: C11H16IN5O4
MF: 409.18
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.88g/cm3
InChIKey: HRVIETAHBNHGAH-YCSZXMBFSA-N
CanonicalSMILES: CN1C=NC2=C(C1=N)N=CN2C3C(C(C(O3)CO)O)O.I
IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methylpurin-9-yl)oxolane-3,4-diol;hydroiodide
InChI: InChI=1S/C11H15N5O4.HI/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11;/h3-5,7-8,11-12,17-19H,2H2,1H3;1H/t5-,7-,8-,11-;/m1./s1
Synonyms: N1-Methyladenosine hydroiodide; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-imino-1-methyl-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diol hydroiodide; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-6,9-dihydro-1H-purin-9-yl)oxolane-3,4-diol hydroiodide; Adenosine, 1-methyl-, hydriodide (1:1); 6-Amino-1-methyl-9-β-D-ribofuranosyl-9H-purinium iodide; Adenosine, 1-methyl-, monohydriodide; NSC 66391
Related CAS: 15763-06-1 (free base)

(E)-N'-(9-((2R,3R,4R,5R)-4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide

Description: (E)-N'-(9-((2R,3R,4R,5R)-4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide, a powerful anticancer drug, effectively targets cancer cells by disrupting DNA replication. By inhibiting DNA polymerase, it interrupts the essential process of cell division, thus making it an effective chemotherapy drug against various tumors. This compound displays immense potential as a potent antineoplastic agent and holds significant promise for advanced cancer treatment.
CAT: BRP-01948
MF: C40H50N6O7Si
MF: 754.95
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.2±0.1 g/cm3
InChIKey: CTUAKQKWOFVGMG-UWPHNAITSA-N
CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N=CN(C)C)CO)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-3-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C40H50N6O7Si/c1-39(2,3)54(8,9)53-34-33(31(23-47)51-37(34)46-25-41-32-35(46)43-38(44-36(32)48)42-24-45(4)5)52-40(26-13-11-10-12-14-26,27-15-19-29(49-6)20-16-27)28-17-21-30(50-7)22-18-28/h10-22,24-25,31,33-34,37,47H,23H2,1-9H3,(H,43,44,48)/b42-24+/t31-,33-,34-,37-/m1/s1
Synonyms: (E)-N'-(9-((2R,3R,4R,5R)-4-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-((tert-butyl Dimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethyl formamidine

SDZ WAG 994

Description: SDZ WAG 994 is a potent and selective adenosine A1 receptor agonist (Ki = 23, > 10000 and 25000 nM for A1, A2A and A2B receptors, respectively). SDZ WAG 994 has been shown to lower blood pressure levels and heart rate in spontaneous hypertensive rats, and inhibit adenosine deaminase-stimulated lipolysis in rat adipocytes (Ki = 8 nM).
CAT: BRP-01949
CAS: 130714-47-5
MF: C17H25N5O4
MF: 363.41
Purity: ≥99% by HPLC
Appearance: Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.59±0.1 g/cm3
Boiling Point: 647.2±65.0°C at 760 mmHg
InChIKey: JAKAFSGZUXCHLF-LSCFUAHRSA-N
Solubility: Soluble in DMSO
CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=CN=C3NC4CCCCC4)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-[6-(cyclohexylamino)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
InChI: InChI=1S/C17H25N5O4/c1-25-14-13(24)11(7-23)26-17(14)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-2-4-6-10/h8-11,13-14,17,23-24H,2-7H2,1H3,(H,18,19,21)/t11-,13-,14-,17-/m1/s1
Synonyms: SDZ-WAG994; Adenosine, N-cyclohexyl-2'-O-methyl-; N-Cyclohexyl-2'-O-methyladenosine; SDZ-WAG 994; WAG 994; N6-cyclohexyl-2-O-methyladenosine; SDZ-WAG-994; (2R,3R,4R,5R)-5-(6-(cyclohexylamino)-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol

8-Oxoadenosine

Description: It is an anticancer antibiotic, oxidized nucleic acid adduct and phosmidosine precursor (P-prodrug). It can be used to treat hemochromatosis.
CAT: BRP-01950
CAS: 29851-57-8
MF: C10H13N5O5
MF: 283.24
Purity: ≥95%
Appearance: White to Off-white Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C under inert atmosphere
Density: 1.806±0.06 g/cm3
Melting Point: >228°C (dec.)
Boiling Point: 776.3°C at 760 mmHg
InChIKey: UEHOMUNTZPIBIL-UUOKFMHZSA-N
Solubility: Soluble in DMSO (Slightly, Sonicated), Methanol (Very Slightly, Sonicated), Water (Slightly)
CanonicalSMILES: C1=NC(=C2C(=N1)N(C(=O)N2)C3C(C(C(O3)CO)O)O)N
IUPAC Name: 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-purin-8-one
InChI: InChI=1S/C10H13N5O5/c11-7-4-8(13-2-12-7)15(10(19)14-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H,14,19)(H2,11,12,13)/t3-,5-,6-,9-/m1/s1
Synonyms: NSC 102240; NSC 90396; 7,8-Dihydro-8-oxoadenosine; 8-Hydroxyadenosine; 8-Oxo-7,8-dihydroadenosine; 6-Amino-7,9-dihydro-9-β-D-ribofuranosyl-8H-purin-8-one; 6-amino-9-(beta-D-ribofuranosyl)purin-8-(7H)-one; (2R,3R,4S,5R)-2-(6-amino-8-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 8-Hydroxyadenosine

N-[1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]benzamide

Description: N-[1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]benzamide, a biomedical compound, is known for its potent action against cancer. It functions as an enzymatic inhibitor, targeting cancerous cells that proliferate with great intensity. It outperforms other treatments when administered against multiple cancer forms. Breast cancer, lung cancer, and melanoma are among the diseases that this drug effectively curbs.
CAT: BRP-01952
CAS: 171721-05-4
MF: C30H23FIN3O7
MF: 683.42
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.62±0.1 g/cm3
InChIKey: JLSSGKUNYKOIPA-LAOBSVPGSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)NC2=NC(=O)N(C=C2I)C3C(C(C(O3)COC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)F
IUPAC Name: [(2S,3S,4R,5S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1-yl)-3-benzoyloxy-4-fluorooxolan-2-yl]methyl benzoate
InChI: InChI=1S/C30H23FIN3O7/c31-23-24(42-29(38)20-14-8-3-9-15-20)22(17-40-28(37)19-12-6-2-7-13-19)41-27(23)35-16-21(32)25(34-30(35)39)33-26(36)18-10-4-1-5-11-18/h1-16,22-24,27H,17H2,(H,33,34,36,39)/t22-,23+,24-,27-/m0/s1
Synonyms: Benzamide, N-[1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,2-dihydro-5-iodo-2-oxo-4-pyrimidinyl]-; (2S,3S,4R,5S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluorotetrahydrofuran-3-yl benzoate; (3R,4S)-5-(4-benzamido-5-iodo-2-oxopyrimidin-1(2H)-yl)-2-(benzoyloxymethyl)-4-fluorotetrahydrofuran-3-yl benzoate

S-Adenosyl-L-methionine chloride

Description: S-Adenosyl-L-methionine chloride (SAM or SAMe) is a vital compound in biochemical and pharmacological research due to its role as a methyl group donor in methylation reactions and its function as a cofactor for numerous enzymes. It is significant in studies related to gene regulation, enzyme mechanisms, and therapeutic applications for depression, liver diseases, and joint health. Additionally, SAMe's availability as a dietary supplement highlights its potential benefits in promoting overall health and well-being.
CAT: BRP-01953
CAS: 24346-00-7
MF: C15H23ClN6O5S
MF: 434.90
Purity: 98%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Application: This material is 80-90% pure when prepared, but is very unstable. Methyl donor; cofactor for enzyme-catalyzed methylations, including catechol O-methyltransferase (COMT) and DNA methyltransferases (DNMT). Although present in all cells, it is concentrated
InChIKey: DYFPQIYEZQULMZ-XKGORWRGSA-N
Solubility: Soluble in Water
CanonicalSMILES: C[S+](CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.[Cl-]
IUPAC Name: [(3S)-3-amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium;chloride
InChI: InChI=1S/C15H22N6O5S.ClH/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21;/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25);1H/t7-,8+,10+,11+,14+,27?;/m0./s1
Synonyms: Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methylsulfonio]-5'-deoxy-, chloride (1:1); Adenosine, 5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxy-, chloride; Adenosine, 5'-[(3-amino-3-carboxypropyl)methylsulfonio]-5'-deoxy-, chloride, (3S)-; Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methylsulfonio]-5'-deoxy-, chloride; Methionine, S-(5-deoxyadenos-5-yl)-, chloride, L-; S-(5-Adenosyl)-L-methionine chloride; S-Adenosylmethionine chloride
Related CAS: 485-80-3 (free base)

2,2'-Anhydro-5'-O-t-butyldiphenylsilyluridine

Description: 2,2'-Anhydro-5'-O-t-butyldiphenylsilyluridine, a remarkable biomedicine, emerges as an invaluable asset in combatting the peril of viral infections, with a precise focus on RNA viruses. As a potent nucleoside analogue, it exerts its therapeutic prowess by skillfully impeding viral replication through the disruption of viral RNA synthesis. Possessing unparalleled efficacy, this exceptional product stands as a formidable antiviral warrior, fiercely combating a myriad of illnesses caused by RNA viruses such as influenza, HIV, and hepatitis C.
CAT: BRP-01957
CAS: 175013-46-4
MF: C25H28N2O5Si
MF: 464.59
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.3±0.1 g/cm3
Melting Point: 181-182 °C
Boiling Point: 558.0±60.0°C at 760 mmHg
InChIKey: LDJBSUUNUJOJTI-XBYSBRQOSA-N
CanonicalSMILES: CC(C)(C)[Si](C1=CC=CC=C1)(C2=CC=CC=C2)OCC3C(C4C(O3)N5C=CC(=O)N=C5O4)O
IUPAC Name: (2R,3R,3aS,9aR)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-3-hydroxy-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
InChI: InChI=1S/C25H28N2O5Si/c1-25(2,3)33(17-10-6-4-7-11-17,18-12-8-5-9-13-18)30-16-19-21(29)22-23(31-19)27-15-14-20(28)26-24(27)32-22/h4-15,19,21-23,29H,16H2,1-3H3/t19-,21-,22+,23-/m1/s1
Synonyms: 5'-O-TBDPS-2,2'-anhydrouridine; 5'-O-(tert-butyldiphenylsilyl)-2,2'-O-anhydrouridine; (2R,4R,5R,6S)-4-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-hydroxy-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one; (2R)-2alpha-[(tert-Butyldiphenylsiloxy)methyl]-3beta-hydroxy-2,3,3abeta,9abeta-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; (2R,3R,3aS,9aR)-2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, [2R-(2α,3β,3aβ,9aβ)]-

5'-O-Benzoyl-2,2'-anhydrouridine

Description: 5'-O-Benzoyl-2,2'-anhydrouridine is a modified nucleoside used in nucleic acid research and chemical synthesis. This compound has a benzoyl group protecting the 5'-hydroxyl position and an anhydro linkage between the 2' and 2'' positions of uridine. The modification can enhance the stability and alter the properties of nucleic acids. It is particularly useful in the synthesis of oligonucleotides and in studies involving RNA structure and function. The presence of the anhydro linkage can help in the formation of specific conformations, making it a valuable tool for probing the biochemical and biophysical properties of RNA.
CAT: BRP-01958
CAS: 24877-18-7
MF: C16H14N2O6
MF: 330.29
Purity: 95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.62±0.1 g/cm3
Melting Point: 198-200 °C
Boiling Point: 522.6±60.0 °C at 760 mmHg
InChIKey: UDIXPZFDRWDWAJ-RUZUBIRVSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C3C(O2)N4C=CC(=O)N=C4O3)O
IUPAC Name: [(2R,4R,5R,6S)-5-hydroxy-10-oxo-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-4-yl]methyl benzoate
InChI: InChI=1S/C16H14N2O6/c19-11-6-7-18-14-13(24-16(18)17-11)12(20)10(23-14)8-22-15(21)9-4-2-1-3-5-9/h1-7,10,12-14,20H,8H2/t10-,12-,13+,14-/m1/s1
Synonyms: ((2R,3R,3aS,9aR)-3-hydroxy-6-oxo-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-2-yl)methyl benzoate; 5'-O-Benzoyl-2,2'-anhydro-D-uridine; (2R,3R,3aS,9aR)-2-[(Benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one; 6H-Furo[2',3':4,5]oxazolo[3,2-c]pyrimidin-6-one, 2-[(benzoyloxy)methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, [2R-(2α,3β,3aβ,9aβ)]-

5'-O-Benzyl-2,2'-anhydrouridine

Description: 5'-O-Benzyl-2,2'-anhydrouridine, an acclaimed biomedicine, displays its prowess in combating both viral infections and cancer. By impeding viral replication and inducing apoptosis in cancerous cells, it manifests itself as both an antiviral and antineoplastic agent.
CAT: BRP-01959
CAS: 2410993-94-9
MF: C16H16N2O5
MF: 316.31
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.53±0.1 g/cm3
Boiling Point: 505.4±60.0 °C at 760 mmHg
InChIKey: SIIADAUAAHGNDX-REBRKWNGSA-N
CanonicalSMILES: O=C1N=C2OC3C(O)C(OC3N2C=C1)COCC=4C=CC=CC4
IUPAC Name: (2R,3R,3aS,9aR)-2-((benzyloxy)methyl)-3-hydroxy-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
InChI: InChI=1S/C16H16N2O5/c19-12-6-7-18-15-14(23-16(18)17-12)13(20)11(22-15)9-21-8-10-4-2-1-3-5-10/h1-7,11,13-15,20H,8-9H2/t11-,13-,14+,15-/m1/s1
Synonyms: 5'-O-Benzyl-2,2'-anhydro-D-uridine; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-[(phenylmethoxy)methyl]-, (2R,3R,3aS,9aR)-; (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-[(phenylmethoxy)methyl]-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one

2,6-Diamino-9-(β-D-arabinofuranosyl)purine

Description: 2,6-Diamino-9-(β-D-arabinofuranosyl)purine, a potent antineoplastic agent, is indicated for the management of chronic lymphocytic leukemia and non-Hodgkin lymphoma. By restraining DNA synthesis, the agent induces apoptosis in rapidly proliferating cancerous cells. Its potential as an efficacious chemotherapeutic has been well-establish through extensive clinical data.
CAT: BRP-01960
CAS: 34079-68-0
MF: C10H14N6O4
MF: 282.26
Purity: ≥95%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.25±0.10 g/cm3
Melting Point: 286-290 °C
Boiling Point: 798.5±70.0 °C at 760 mmHg
InChIKey: ZDTFMPXQUSBYRL-FJFJXFQQSA-N
CanonicalSMILES: C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)N)N
IUPAC Name: (2R,3S,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H14N6O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H4,11,12,14,15)/t3-,5-,6+,9-/m1/s1
Synonyms: DAPA; 2,6-Diamino-9-(b-D-arabinofuranosyl)purine; 2,6-Diaminopurine-9-arabinoside; araDAP; araDAPR; (2R,3S,4S,5R)-2-(2,6-Diamino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-β-D-Arabinofuranosyl-9H-purine-2,6-diamine; 2,6-Diamino-9-β-D-arabinofuranosylpurine; 9-β-D-Arabinofuranosyl-2,6-diaminopurine

5-Bromoarabinouridine

Description: 5-Bromoarabinouridine, known for its significant role in biomedical research, emerges as a nucleoside analog warranting attention. Operating as an effective combatant against selected viral infections and cancers, it bestows antiviral and antitumor prowess by impeding viral replication and perturbing DNA synthesis.
CAT: BRP-01961
CAS: 3370-69-2
MF: C9H11BrN2O6
MF: 323.10
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.043±0.06 g/cm3
InChIKey: AGFIRQJZCNVMCW-MNCSTQPFSA-N
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)Br
IUPAC Name: 5-bromo-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11BrN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6+,8-/m1/s1
Synonyms: 1-(β-D-Arabinofuranosyl)-5-bromouracil; 1-(β-D-Arabinofuranosyl)-5-bromo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-bromo-; 5-Bromo-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-bromo-; 1-β-D-Arabinofuranosyl-5-bromouracil; NSC 82222

5-Iodoarabinouridine

Description: 5-Iodoarabinouridine, a biomedical compound, displays remarkable potential for research of various diseases. Exerting its influence as an RNA research and development inhibitor, this compound takes center stage in the arena of cancer research. Its proficiency lies in the selective targeting of RNA molecules, effectively curbing the malignant growth and propagation of cancer cells.
CAT: BRP-01962
CAS: 3052-06-0
MF: C9H11IN2O6
MF: 370.10
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.27±0.1 g/cm3
Melting Point: 196-199 °C
InChIKey: RKSLVDIXBGWPIS-MNCSTQPFSA-N
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)I
IUPAC Name: 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
InChI: InChI=1S/C9H11IN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6+,8-/m1/s1
Synonyms: 1-(β-D-Arabinofuranosyl)-5-iodouracil; NSC 82221; I-araU; 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-iodo-; 1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione; 1-β-D-Arabinofuranosyl-5-iodo-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-5-iodo-; 1-β-D-Arabinofuranosyl-5-iodouracil; NSC 82221

N1-Methyl ara-uridine

Description: N1-Methyl ara-uridine is an exceptional compound, holding applications in studying diverse diseases such as cancer. It has the remarkable capability to selectively target malignant cells. By functioning as a robust inhibitor, it obstructs the rampant growth of cancerous cells while facilitating programmed cell death.
CAT: BRP-01963
CAS: 17676-62-9
MF: C10H14N2O6
MF: 258.23
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.605±0.06 g/cm3 (Predicted)
Boiling Point: 501.1±60.0 °C at 760 mmHg
InChIKey: UTQUILVPBZEHTK-BUJSFMDZSA-N
CanonicalSMILES: CN1C(=O)C=CN(C1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-methylpyrimidine-2,4(1H,3H)-dione
InChI: InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3/t5-,7-,8+,9-/m1/s1
Synonyms: 2,4(1H,3H)-Pyrimidinedione, 1-β-D-arabinofuranosyl-3-methyl-; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyrimidine-2,4-dione; 1-beta-D-Arabinofuranosyl-3-methyluracil; 1-(β-D-Arabinofuranosyl)-3-methyl-2,4(1H,3H)-pyrimidinedione; 1-β-D-Arabinofuranosyl-3-methyl-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-D-arabinofuranosyl-3-methyl-; 1-β-D-Arabinofuranosyl-3-methyluracil

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-aracytidine

Description: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-aracytidine, a highly esteemed and significant compound extensively employed in the biomedical sector, exhibits immense potential. This geological marvel assumes a paramount position in combating viral afflictions, encompassing select strains of herpes and malignancies attributed to viral etiology.
CAT: BRP-01964
CAS: 87418-76-6
MF: C37H35N3O8
MF: 649.69
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.31±0.1 g/cm3
InChIKey: KCLOEKUQZJAMFG-RWJNZVCKSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)O)O
IUPAC Name: N-(1-((2R,3S,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
InChI: InChI=1S/C37H35N3O8/c1-45-28-17-13-26(14-18-28)37(25-11-7-4-8-12-25,27-15-19-29(46-2)20-16-27)47-23-30-32(41)33(42)35(48-30)40-22-21-31(39-36(40)44)38-34(43)24-9-5-3-6-10-24/h3-22,30,32-33,35,41-42H,23H2,1-2H3,(H,38,39,43,44)/t30-,32-,33+,35-/m1/s1
Synonyms: N-(1-{(2R,3S,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-3,4-dihydroxy-tetrahydro-furan-2-yl}-2-oxo-1,2-dihydro-pyrimidin-4-yl)-benzamide; N-Benzoyl-5'-(di-p-methoxytrityl)aracytidine; N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-β-D-arabinofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide; N4-Bz-5'-O-DMT-araC

Adenosine HCl

Description: Adenosine hydrochloride is a hydrochloride salt form of adenosine, a nucleoside composed of adenine and ribose. Adenosine plays a crucial role in biochemical processes such as energy transfer (e.g., ATP) and signal transduction as a neurotransmitter. In its monohydrochloride form, adenosine is more soluble in water, making it useful for various biochemical and pharmaceutical applications. This compound is employed in research focused on cellular metabolism, enzyme functions, and nucleic acid interactions. Additionally, adenosine monohydrochloride is used in studies investigating the effects of adenosine on cardiovascular and neurological functions.
CAT: BRP-01965
CAS: 58056-57-8
MF: C10H13N5O4.xHCl
MF: 267.24 (free base)
Purity: ≥98% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: YFJCRJZTDYDCRZ-MCDZGGTQSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.Cl
IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrochloride
InChI: InChI=1S/C10H13N5O4.ClH/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H/t4-,6-,7-,10-;/m1./s1
Synonyms: Adenosine hydrochloride; Adenosine hydrochloride (1:x); (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hydrochloride; 9-β-D-Ribofuranosyl-9H-purin-6-amine hydrochloride; 9-β-D-Ribofuranosyladenine hydrochloride; D-Adenosine hydrochloride; Adenine riboside hydrochloride; β-D-Adenosine hydrochloride; β-Adenosine hydrochloride
Related CAS: 58-61-7 (free base) ; 19065-22-6 (monohydrochloride )

N4-Benzoyl-L-cytidine

Description: N4-Benzoyl-L-cytidine, an innovative biomedical compound, showcases promising applications in therapeutic settings. With a primary focus on breast and colon cancers, its utilization proves pivotal in curtailing tumor progression and bolstering cancer cell apoptosis. Broadening horizons for biomedical research, this indispensable entity's extraordinary chemical attributes lay the foundation for creating precise, targeted therapies catering to distinct cancer subtypes.
CAT: BRP-01966
CAS: 1018812-31-1
MF: C16H17N3O6
MF: 347.32
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.59±0.1 g/cm3
InChIKey: BNXBRFDWSPXODM-NHULGOKLSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)NC2=NC(=O)N(C=C2)C3C(C(C(O3)CO)O)O
IUPAC Name: N-[1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C16H17N3O6/c20-8-10-12(21)13(22)15(25-10)19-7-6-11(18-16(19)24)17-14(23)9-4-2-1-3-5-9/h1-7,10,12-13,15,20-22H,8H2,(H,17,18,23,24)/t10-,12-,13-,15-/m0/s1
Synonyms: N-Benzoyl-L-cytidine; N4-Benzoylcytidine; N-(1,2-Dihydro-2-oxo-1-β-L-ribofuranosyl-4-pyrimidinyl)benzamide; N-(1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; L-C(Bz)

2',3'-Di-O-benzoyl-N6-benzoyl-L-adenosine

Description: 2',3'-Di-O-benzoyl-N6-benzoyl-L-adenosine, a specialized compound extensively employed in the biomedical sector, demonstrates tremendous promise as an antiviral entity, effectively combatting a wide array of ailments induced by viral invasions. Remarkably efficient in impeding the replication of specific viruses, this remarkable agent exhibits immense potential for advancing the realm of antiviral therapeutics and pharmaceutical interventions.
CAT: BRP-01967
CAS: 200562-12-5
MF: C31H25N5O7
MF: 579.56
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.45±0.1 g/cm3
InChIKey: PDOVRTQXHVPGAF-CFRBSIFHSA-N
CanonicalSMILES: C1=CC=C(C=C1)C(=O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)OC(=O)C5=CC=CC=C5)OC(=O)C6=CC=CC=C6
IUPAC Name: [(2S,3S,4S,5S)-5-(6-benzamidopurin-9-yl)-4-benzoyloxy-2-(hydroxymethyl)oxolan-3-yl] benzoate
InChI: InChI=1S/C31H25N5O7/c37-16-22-24(42-30(39)20-12-6-2-7-13-20)25(43-31(40)21-14-8-3-9-15-21)29(41-22)36-18-34-23-26(32-17-33-27(23)36)35-28(38)19-10-4-1-5-11-19/h1-15,17-18,22,24-25,29,37H,16H2,(H,32,33,35,38)/t22-,24-,25-,29-/m0/s1
Synonyms: Benzamide, N-[9-(2,3-di-O-benzoyl-β-L-ribofuranosyl)-9H-purin-6-yl]-; N-[9-(2,3-Di-O-benzoyl-β-L-ribofuranosyl)-9H-purin-6-yl]benzamide; N6,2',3'-O-tribenzoyl-L-adenosine; N6-benzoyl-9-(2',3'-di-O-benzoyl-β-L-ribofuranosyl)adenine; (2S,3S,4S,5S)-2-(6-benzamido-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl dibenzoate
* Only for research. Not suitable for any diagnostic or therapeutic use.

logo

Global Supplier of High-Quality RNA / DNA Products & Services.

        Ordering
Copyright © 2024 BOC Sciences. All rights reserved.
USA
    • International:
    • US & Canada (Toll free):
  • Fax:
  • Email:
UK
  • Tel:
  • Email:
Inquiry Basket
Loading ......
Delete selectedGo to checkout